Minerva Neurosciences, Inc.

NERV ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $56.9M

Liabilities Breakdown FY2023

Total Liabilities: $85.4M